| Quarter | Score |
|---|---|
| 2019-Q1 | 47.3 |
| 2019-Q3 | 42.4 |
| 2019-Q4 | 44.2 |
| 2022-Q1 | 51.9 |
| 2022-Q2 | 59.1 |
| 2022-Q3 | 49.5 |
| 2022-Q4 | 51.0 |
| 2023-Q1 | 56.0 |
| 2023-Q2 | 52.5 |
| 2023-Q3 | 59.0 |
| 2023-Q4 | 79.9 |
| 2024-Q1 | 48.1 |
| 2024-Q2 | 41.2 |
| 2024-Q3 | 91.0 |
| 2024-Q4 | 87.2 |
Funds reducing exposure or consensus momentum fading
No price reference available to measure drift vs fund cost basis
3 of 18 tracked funds hold CEIX. Avg conviction: 10.9%. Net trimming. First tracked at $103.28.
Current price unavailable — check back later
Pabrai Investment Funds has 25.0% in this stock
Too early to measure — check back next quarter
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Pabrai Investment Funds | 25.0% | Reduce |
| Greenlight Capital | 7.7% | Reduce |
| Citadel Advisors | 0.0% | Reduce |